Clinical Evaluation of a Novel Textile Radiation Protection Device
Evaluation of Novel Woven Fabric Radiation Protection Gear for Head and Neck Regions for Interventional Radiology Personnel
研究概览
详细说明
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Michael Kassin, MD
- 电话号码:770-712-6913
- 邮箱:michael.t.kassin@emory.edu
学习地点
-
-
Georgia
-
Atlanta、Georgia、美国、30322
- Emory University Hospital
-
接触:
- Michael U Kassin, MD
- 电话号码:770-712-6913
- 邮箱:michael.t.kassin@emory.edu
-
Atlanta、Georgia、美国、30308
- Emory University Hospital Midtown
-
接触:
- Michael UH Kassin, MD
- 电话号码:770-712-6913
- 邮箱:michael.t.kassin@emory.edu
-
接触:
- Emory UH Midtown
-
Atlanta、Georgia、美国、30308
- Winship Cancer Institute
-
接触:
- Michael UH Kassin, MD
- 电话号码:770-712-6913
- 邮箱:michael.t.kassin@emory.edu
-
接触:
- Emory UH Midtown
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Age ≥18 years.
- Employed or regularly working in the IR department at the study site.
- Routinely present in fluoroscopy-guided procedures (e.g., IR attending, IR trainee, technologist, IR nurse, anesthesia provider).
- Scheduled to work in procedure rooms equipped with Texray garments and dosimetry systems during the study period.
- Willing and able to provide informed consent.
- Willing to wear Texray PPE and/or standard PPE with dosimeters as specified by the study protocol.
Exclusion Criteria:
- Age <18 years.
- Not regularly present in IR suites during fluoroscopy-based procedures.
- Known pregnancy at the time of enrollment.
- Presence of a musculoskeletal or dermatologic condition that, in the opinion of the investigator or the participant, would prevent safe use of the Texray garments (e.g., inability to tolerate additional weight or fabric contact).
- Decline to participate or are unable to provide informed consent.
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:非随机化
- 介入模型:交叉作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Group A: Standard Personal Protective Equipment (PPE) only then Texray PPE
Participants in Group A will wear their usual radiation personal protection equipment (PPE) during procedures for the first 4 weeks.
After completing a brief orientation and fitting session for the Texray personal protective equipment (PPE), they will wear the HeadPeace (non-lead head protector) and MindPeace (non-lead thyroid and face protector) during procedures for the following 4 weeks.
|
Standard PPE (Baseline Phase): Participants wear their usual radiation protection equipment, including standard lead aprons and thyroid collars (and any head coverings they already use). Personal dosimeters are placed at predefined anatomical regions mimicking Texray coverage (e.g., forehead, temples, anterior/lateral thyroid) over standard PPE. These readings provide baseline scatter radiation exposure under current clinical conditions. Texray PPE (Intervention Phase): During the intervention phase, participants wear HeadPeace (non-lead head protector) and MindPeace (non-lead thyroid and face protector) during procedures. Each garment includes internal and external dosimeter pockets at key anatomical sites to enable paired measurements beneath and outside the shield. These data support calculation of percent dose reduction and attenuation at specific sites. |
|
实验性的:Texray PPE then Standard PPE only
Participants in Group B will complete a brief orientation and fitting session for the Texray personal protective equipment (PPE) and will wear the HeadPeace (non-lead head protector) and MindPeace (non-lead thyroid and face protector) during procedures for the first 4 weeks.
They will then switch to wearing their usual radiation PPE during procedures for the following 4 weeks.
|
Standard PPE (Baseline Phase): Participants wear their usual radiation protection equipment, including standard lead aprons and thyroid collars (and any head coverings they already use). Personal dosimeters are placed at predefined anatomical regions mimicking Texray coverage (e.g., forehead, temples, anterior/lateral thyroid) over standard PPE. These readings provide baseline scatter radiation exposure under current clinical conditions. Texray PPE (Intervention Phase): During the intervention phase, participants wear HeadPeace (non-lead head protector) and MindPeace (non-lead thyroid and face protector) during procedures. Each garment includes internal and external dosimeter pockets at key anatomical sites to enable paired measurements beneath and outside the shield. These data support calculation of percent dose reduction and attenuation at specific sites. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Radiation dose comparing standard PPE vs. Texray PPE groups
大体时间:Baseline, 4 and 8 weeks post-intervention
|
Radiation dose to the head and thyroid region (mSv), as measured by personal dosimeters during fluoroscopy-guided procedures, comparing standard PPE vs. Texray PPE groups.
|
Baseline, 4 and 8 weeks post-intervention
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Role-specific radiation dose
大体时间:Baseline, 4 and 8 weeks post-intervention
|
Role-specific radiation dose in mSv will be measured (attending IR, trainee, technologist, nurse, anesthesia) comparing standard PPE vs. Texray PPE groups.
|
Baseline, 4 and 8 weeks post-intervention
|
|
Procedure-specific radiation dose
大体时间:Baseline, 4 and 8 weeks post-intervention
|
Procedure-specific radiation dose in mSv (e.g., liver-directed therapy, embolization, venography, line and port placement) will be measured comparing standard PPE vs. Texray PPE groups.
|
Baseline, 4 and 8 weeks post-intervention
|
|
Radiation dose and attenuation stratified by fluoroscopy room
大体时间:Baseline, 4 and 8 weeks post-intervention
|
Radiation dose will be measured comparing standard PPE vs. Texray PPE groups stratified by fluoroscopy room and equipment age (new vs. legacy systems).
|
Baseline, 4 and 8 weeks post-intervention
|
|
Number of participants with correct donning/doffing placement of the PPE
大体时间:Baseline, 4 and 8 weeks post-intervention
|
Number of participants with correct PPE donning/doffing will be recorded.
|
Baseline, 4 and 8 weeks post-intervention
|
合作者和调查者
调查人员
- 首席研究员:Zachary Bercu, MD、Emory University
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- 2025P011985
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
IPD 共享时间框架
IPD 共享访问标准
IPD 共享支持信息类型
- 研究方案
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.